Skip to Main Content

Paper Details

Neurocognitive trajectory and proteomic signature of inherited risk for Alzheimer's disease.
PLoS Genet
2
2022
Author NameAffiliation
Mark ChaffinBroad Institute of MIT and Harvard
Jerome I RotterThe Institute for Translational Genomics and Population Sciences, The Lundquist Institute for Biomedical Innovation at Harbor-University of California, Los Angeles Medical Center
Stephen S RichCenter for Public Health Genomics, University of Virginia
Robert E GersztenBroad Institute of MIT and Harvard
Robert E GersztenBeth Israel Deaconess Medical Center and Harvard Medical School.
Xiuqing GuoThe Institute for Translational Genomics and Population Sciences, The Lundquist Institute for Biomedical Innovation at Harbor-University of California, Los Angeles Medical Center
Susan R HeckbertUniversity of Washington
Russell P TracyLarner College of Medicine, University of Vermont
John DaneshBritish Heart Foundation Cardiovascular Epidemiology Unit, University of Cambridge
John DaneshNational Institute for Health Research Blood and Transplant Research Unit in Donor Health and Genomics, University of Cambridge
John DaneshWellcome Sanger Institute
John DaneshWellcome Genome Campus and University of Cambridge
John DaneshNational Institute for Health Research Cambridge Biomedical Research Centre, University of Cambridge and Cambridge University Hospitals
John DaneshBritish Heart Foundation Centre of Research Excellence, University of Cambridge
Eric S LanderBroad Institute of MIT and Harvard
Eric S LanderHarvard Medical School
Eric S LanderMassachusetts Institute of Technology
Eric S LanderBroad Institute of MIT and Harvard
Eric S LanderMassachusetts Institute of Technology
Eric S LanderHarvard Medical School
Michael InouyeUniversity of Cambridge
Michael InouyeThe Alan Turing Institute
Michael InouyeUniversity of Melbourne
Michael InouyeWellcome Genome Campus and University of Cambridge
Michael InouyeNational Institute for Health Research Cambridge Biomedical Research Centre, University of Cambridge and Cambridge University Hospitals
Michael InouyeBritish Heart Foundation Centre of Research Excellence, University of Cambridge
Michael InouyeBritish Heart Foundation Cardiovascular Epidemiology Unit, University of Cambridge
Michael InouyeBaker Heart & Diabetes Institute
Sekar KathiresanBroad Institute of MIT and Harvard
Sekar KathiresanHarvard Medical School
Sekar KathiresanDivision of Cardiology and Center for Genomic Medicine, Massachusetts General Hospital
Sekar Kathiresan
Adam S ButterworthBritish Heart Foundation Cardiovascular Epidemiology Unit, University of Cambridge
Adam S ButterworthBritish Heart Foundation Centre of Research Excellence, University of Cambridge
Adam S ButterworthNational Institute for Health Research Cambridge Biomedical Research Centre, University of Cambridge and Cambridge University Hospitals
Adam S ButterworthWellcome Genome Campus and University of Cambridge
Adam S ButterworthNational Institute for Health Research Blood and Transplant Research Unit in Donor Health and Genomics, University of Cambridge
Adam S ButterworthBritish Heart Foundation Cardiovascular Epidemiology Unit, University of Cambridge
Adam S ButterworthBritish Heart Foundation Centre of Research Excellence, University of Cambridge
Adam S ButterworthNational Institute for Health Research Cambridge Biomedical Research Centre, University of Cambridge and Cambridge University Hospitals
Adam S ButterworthWellcome Genome Campus and University of Cambridge
Adam S ButterworthNational Institute for Health Research Blood and Transplant Research Unit in Donor Health and Genomics, University of Cambridge
Amit KheraBroad Institute of MIT and Harvard
Amit Khera
Amit KheraDivision of Cardiology and Center for Genomic Medicine, Massachusetts General Hospital
Amit KheraHarvard Medical School
  • 1 - 46

Datasets